Reportlinker Adds United States Patient Monitoring Investment Opportunities, Analysis and Forecasts to 2015 Report

Reportlinker.com announces that a new market research report is available in its catalogue.

United States Patient Monitoring Investment Opportunities, Analysis and Forecasts to 2015

http://www.reportlinker.com/p0109554/United-States-Patient-Monitoring-Investment-Opportunities-Analysis-and-Forecasts-to-2015.html

United States Patient Monitoring Investment Opportunities, Analysis and Forecasts to 2015

Summary

This report is an essential source for in-depth information and data relating to the USA patient monitoring devices market. It also offers detailed and comprehensive coverage of market revenue, volume, distribution and company share information; and latest news, financial deals and pipeline products information of each of the key sub-segments of the patient monitoring devices in USA

Scope

• The report provides patient monitoring devices information broken down into detailed categories and segments in United States.
• Total revenues, products sold, end users, and average pricing.
• Market shares of all the key competitors.
• Key pipeline products that are set to shape the market, broken down by sector.
• Information on the top medical equipment companies in the sector in the country covering business description, strategic analysis, and financial information.
• Healthcare structure, regulatory environment, approval process, pricing trends and reimbursement.
• Product and brand updates, strategy changes, R&D projects, corporate expansions and contractions and regulatory changes.
• Key mergers and acquisitions, partnerships, private equity investments and IPOs.
• Customer, hospitals and physicians data.

Reasons to buy

• Gain a strong understanding of the patient monitoring devices market in United States.
• Evaluate and compare the attractiveness of the market in the country.
• Identify growth segments and opportunities in each industry sector within the country.
• Evaluate the pipeline of key products that will change the sector, and identify threats and opportunities before the products are launched in the country.
• Analyze the competitiveness of the market in the country and identify hotspots.
• Develop strategies based on the latest product, brand, expansion and research and development news in the country.
• Do deals with an understanding of how competitors are financed, and the mergers and partnerships that have shaped the market in the country.
• Identify and analyze the strengths and weaknesses of the industry incumbents in the country.

1 Table Of Contents 2 3

2 Introduction 17

2.1 What Is This Report About? 17

3 Definitions of Markets Covered in This Report 18

3.1 Patient Monitoring 18

3.2 Wireless Ambulatory Telemetry Monitoring 18

3.2.1 Hospital Ambulatory 18

3.2.2 Cardiac Rehabilitation 18

3.3 Multiparameter Patient Monitoring 18

3.3.1 Critical Care Monitors 18

3.3.2 Perioperative Care Monitors 18

3.4 Remote Patient Monitoring 18

3.5 Non-Invasive Blood Pressure Monitors 19

3.5.1 Mercury Sphygmomanometer 19

3.5.2 Aneroid Sphygmomanometer 19

3.5.3 Automatic Sphygmomanometer 19

3.6 Micro- Electromechanical Systems (MEMS) 19

4 Healthcare Sector Review 20

4.1 Healthcare Expenditure 20

4.2 Healthcare Infrastructure 25

4.2.1 Healthcare Personnel Data 27

4.2.2 Healthcare Facilities Data 31

4.3 United States Healthcare Trade Statistics 33

5 Regulation System 34

5.1 Regulation System 34

5.2 Medical Equipment Approval Process 34

5.2.1 Pre-market Approval Process 35

5.2.2 Intended use and Indications for use 35

5.2.3 Predicate Device 36

5.2.4 Safe and Effective 36

5.2.5 Other Category Devices 38

5.2.6 Post-Market Approval Process 39

5.2.7 Compliance and Enforcement 39

5.2.8 Registration Fee 40

5.2.9 Approval Time 40

6 Pricing and Reimbursement 41

6.1 Government Policies 41

6.2 Private Insurance 42

6.3 Diagnosis Related Groups (DRG) 43

7 Distribution Structure 44

7.1 Distribution Structure 44

8 Patient Monitoring In United States 45

8.1 Patient Monitoring Cross Country Comparison, Revenue ($ mn), 2000-2015 45

8.2 Patient Monitoring, United States, Overall Revenue ($ mn), 2000-2015 46

8.3 Patient Monitoring, United States, Overall Volume (Units), 2000-2015 50

8.4 Patient Monitoring, United States, Company Share (2006-2007) 52

9 Micro-Electromechanical Systems In United States 53

9.1 Micro-Electromechanical Systems Overall Revenue (2000-2015) 53

9.2 Micro-Electromechanical Systems Overall Volume (2000-2015) 55

9.3 Micro-Electromechanical Systems Average Price (2000-2015) 57

9.4 Micro-Electromechanical Systems Distribution Share (2007-2008) 58

9.5 Micro-Electromechanical Systems, United States, Company Share (2006-2007) 59

10 Multiparameter Patient Monitoring In United States 60

10.1 Multiparameter Patient Monitoring Overall Revenue (2000-2015) 60

10.2 Multiparameter Patient Monitoring Overall Volume (2000-2015) 62

10.3 Multiparameter Patient Monitoring Average Price (2000-2015) 64

10.4 Multiparameter Patient Monitoring Distribution Share (2007-2008) 65

10.5 Multiparameter Patient Monitoring, United States, Company Share (2006-2007) 66

11 Non-Invasive Blood Pressure Monitors In United States 67

11.1 Non-Invasive Blood Pressure Monitors Overall Revenue (2000-2015) 67

11.2 Non-Invasive Blood Pressure Monitors Overall Volume (2000-2015) 69

11.3 Non-Invasive Blood Pressure Monitors Average Price (2000-2015) 71

11.4 Non-Invasive Blood Pressure Monitors Distribution Share (2007-2008) 72

11.5 Non-Invasive Blood Pressure Monitors, United States, Company Share (2006-2007) 73

12 Remote Patient Monitoring In United States 74

12.1 Remote Patient Monitoring Overall Revenue (2000-2015) 74

12.2 Remote Patient Monitoring Overall Volume (2000-2015) 76

12.3 Remote Patient Monitoring Average Price (2000-2015) 78

12.4 Remote Patient Monitoring Distribution Share (2007-2008) 78

12.5 Remote Patient Monitoring, United States, Company Share (2006-2007) 79

13 Wireless and Ambulatory Monitoring In United States 80

13.1 Wireless and Ambulatory Monitoring Overall Revenue (2000-2015) 80

13.2 Wireless and Ambulatory Monitoring Overall Volume (2000-2015) 82

13.3 Wireless and Ambulatory Monitoring Average Price (2000-2015) 84

13.4 Wireless and Ambulatory Monitoring Distribution Share (2007-2008) 85

13.5 Wireless and Ambulatory Monitoring, United States, Company Share (2006-2007) 86

14 GE Healthcare Company Profile 87

14.1 Company Overview 87

14.2 GE Healthcare Pipeline Products 87

14.2.1 GE Healthcare Pipeline Products by Equipment Type 87

14.2.2 GE Healthcare Pipeline Products by Development Stage 87

14.2.3 GE Healthcare Pipeline Products by Therapy Area 88

14.2.4 GE Healthcare Pipeline Products by Clinical Trials 88

15 Philips Healthcare Company Profile 89

15.1 Company Overview 89

15.2 Value Chain Analysis 90

15.2.1 Manufacturing 91

15.2.1.1 In House Manufacturing 91

15.2.1.2 Outsourcing 91

15.2.2 Product Development 91

15.2.2.1 Regulatory Approvals 91

15.2.2.2 Clinical Trials 91

15.2.2.3 Research and Development 92

15.2.3 Sales and Marketing 92

15.2.3.1 Partnerships and Alliances 92

15.2.3.2 Licensing Agreements 92

15.2.3.3 E-distribution 92

15.3 Philips Medical Systems Pipeline Products 93

15.3.1 Philips Medical Systems Pipeline Products by Equipment Type 93

15.3.2 Philips Medical Systems Pipeline Products by Development Stage 93

15.3.3 Philips Medical Systems Pipeline Products by Therapy Area 93

15.3.4 Philips Medical Systems Pipeline Products by Clinical Trials 94

15.3.5 Philips Medical Systems Pipeline Products by News Summary 94

16 OMRON HEALTHCARE Co., Ltd. Company Profile 95

16.1 Company Overview 95

16.2 OMRON HEALTHCARE Co., Ltd. Pipeline Products 96

16.2.1 OMRON HEALTHCARE Co., Ltd. Pipeline Products By Equipment Type 96

16.2.2 OMRON HEALTHCARE Co., Ltd. Pipeline Products By Development Stage 96

16.2.3 OMRON HEALTHCARE Co., Ltd. Pipeline Products By Therapy Area 96

16.2.4 OMRON HEALTHCARE Co., Ltd. Pipeline Products By News Summary 96

17 OSI Systems, Inc. Company Profile 97

17.1 Company Overview 97

17.2 Value Chain Analysis 97

17.2.1 Manufacturing 98

17.2.1.1 In House Manufacturing 98

17.2.1.2 Outsourcing 98

17.2.2 Product Development 98

17.2.2.1 Research and Development 98

17.2.2.2 Regulatory Approvals 98

17.2.3 Sales and Marketing 98

17.2.3.1 Licensing Agreements 98

17.2.3.2 Partnerships and Alliances 98

18 Abbott Laboratories Company Profile 99

18.1 Company Overview 99

18.2 Value Chain Analysis 100

18.2.1 Manufacturing 101

18.2.1.1 In House Manufacturing 101

18.2.2 Product Development 101

18.2.2.1 Regulatory Approvals 101

18.2.2.2 Research and Development 101

18.2.2.3 Clinical Trials 101

18.2.3 Sales and Marketing 102

18.2.3.1 Partnerships and Alliances 102

18.3 Abbott Laboratories Pipeline Products 103

18.3.1 Abbott Laboratories Pipeline Products By Equipment Type 103

18.3.2 Abbott Laboratories Pipeline Products By Development Stage 103

18.3.3 Abbott Laboratories Pipeline Products by Therapy Area 103

18.3.4 Abbott Laboratories Pipeline Products by Clinical Trials 103

18.3.5 Abbott Laboratories Pipeline Products by News Summary 104

19 Analogic Corporation Company Profile 105

19.1 Company Overview 105

19.2 Value Chain Analysis 106

19.2.1 Manufacturing 107

19.2.1.1 In House Manufacturing 107

19.2.2 Product Development 107

19.2.2.1 Regulatory Approvals 107

19.2.2.2 Research and Development 107

19.2.3 Sales and Marketing 107

19.2.3.1 Partnerships and Alliances 107

19.2.3.2 Licensing Agreements 107

19.2.3.3 E-distribution 108

19.3 Analogic Corporation Pipeline Products 108

19.3.1 Analogic Corporation Pipeline Products By Equipment Type 108

19.3.2 Analogic Corporation Pipeline Products By Development Stage 108

19.3.3 Analogic Corporation Pipeline Products By Therapy Area 108

20 CAS Medical Systems, Inc. Company Profile 109

20.1 Company Overview 109

21 Critical Signal Technologies Company Profile 110

21.1 Company Overview 110

21.2 Critical Signal Technologies Pipeline Products 110

21.2.1 Critical Signal Technologies Pipeline Products by Equipment Type 110

21.2.2 Critical Signal Technologies Pipeline Products by Development Stage 110

21.2.3 Critical Signal Technologies Pipeline Products by Therapy Area 110

22 Criticare Systems, Inc. Company Profile 111

22.1 Company Overview 111

23 EarlySense Company Profile 112

23.1 Company Overview 112

23.2 EarlySense Pipeline Products 112

23.2.1 EarlySense Pipeline Products by Equipment Type 112

23.2.2 EarlySense Pipeline Products by Development Stage 112

23.2.3 EarlySense Pipeline Products by Therapy Area 112

23.2.4 EarlySense Pipeline Products by Clinical Trials 113

23.2.5 EarlySense Pipeline Products by News Summary 113

24 Hypertension Diagnostics, Inc. Company Profile 114

24.1 Company Overview 114

24.2 Hypertension Diagnostics, Inc. Pipeline Products 114

24.2.1 Hypertension Diagnostics, Inc. Pipeline Products by Equipment Type 114

24.2.2 Hypertension Diagnostics, Inc. Pipeline Products by Development Stage 114

24.2.3 Hypertension Diagnostics, Inc. Pipeline Products by Therapy Area 114

25 Welch Allyn Inc. Company Profile 115

25.1 Company Overview 115

26 Woolsthorpe, LLC Company Profile 116

26.1 Company Overview 116

26.2 Woolsthorpe, LLC Pipeline Products 116

26.2.1 Woolsthorpe, LLC Pipeline Products by Equipment Type 116

26.2.2 Woolsthorpe, LLC Pipeline Products by Development Stage 116

26.2.3 Woolsthorpe, LLC Pipeline Products by Therapy Area 116

26.2.4 Woolsthorpe, LLC Pipeline Products by Clinical Trials 117

26.2.5 Woolsthorpe, LLC Pipeline Products by News Summary 117

27 Zassi Medical Evolutions, LLC Company Profile 118

27.1 Company Overview 118

28 Zoe Medical, Incorporated Company Profile 119

28.1 Company Overview 119

29 Financial Deals Landscape 120

29.1 Acquisition 120

29.1.1 Adidas International Acquires Textronics from Physic Ventures 120

29.1.2 GE Healthcare to Acquire Minority Interest in Living Independently Group 121

29.2 Partnerships 122

29.2.1 Welch Allyn and ZOLL Medical Form Partnership 122

29.2.2 GE Healthcare Enters Into an Agreement with Living Independently Group 123

29.2.3 SunTech Medical Enters Into an Agreement with GE Healthcare 124

30 Recent Developments 125

30.1 Product News 125

30.1.1 Jan 07, 2009: Cheetah Medical Receives FDA Clearance for NICOM Hemodynamic Monitoring System 125

30.1.2 Dec 04, 2008: New Study Reveals Elevated Central Pulse Pressure in African-American Men 125

30.1.3 Nov 24, 2008: VivoMetrics’ LifeShirt Selected By Concordia University to Provide Patient Data for Healthy Heart Research Project 126

30.1.4 Nov 18, 2008: InterCure Announces Launch of RESPeRATE Ultra 126

30.1.5 Nov 10, 2008: Intel Announces Its First Home Medical Device to Better Connect Clinicians with Patients 127

30.1.6 Nov 10, 2008: Intel Announces Its First Home Medical Device to Better Connect Clinicians with Patients 127

30.1.7 Nov 06, 2008: Hemametrics Announces New Study Demonstrating That Crit-Line Use May Contribute To Reduction of Hemoglobin Variability in Hemodialysis Patients 128

30.1.8 Oct 20, 2008: SunTech Medical, Inc. Introduces Next Generation of OEM NIBP Module 128

30.1.9 Oct 17, 2008: SunTech Medical Introduces Next Generation of OEM NIBP Module 129

30.1.10 Oct 13, 2008: Integrated Medical Systems Receives FDA Clearance for World's First 'Suitcase' Intensive Care Unit 129

30.1.11 Oct 10, 2008: Hemodialysis CenterCrit-Line Provides Optimal Fluid Management And Reliable Dry Weight Prediction 129

30.1.12 Oct 06, 2008: Hoana Medical Expands Product Offering With New LifeGurney 130

30.1.13 Sep 25, 2008: OBS Medical Receives New FDA 510(k) Clearance Expanding Visensia Solutions For Hospital Patient Safety 130

30.1.14 Sep 15, 2008: Radiometer Releases ABL80 FLEX CO-OX Portable Analyzer For Sale In The United States 130

30.1.15 Sep 02, 2008: SunTech Medical OEM NIBP Technology for EMS Patient Transport Excels Against Recognized Standard 131

30.1.16 Aug 27, 2008: IBT Announces First FDA-Approved Neurodiagnostic Device 131

30.1.17 Aug 22, 2008: Intel Launches First Medical Device 131

30.1.18 Aug 22, 2008: Intel Will Launch Its First Medical Device 131

30.1.19 Aug 18, 2008: OSI Systems Announces New Generation of Ultra-Lightweight, Versatile Patient Monitors 132

30.1.20 Aug 04, 2008: Radiometer Announces FDA 510(k) Clearance for the ABL80 FLEX Blood Gas Analyzer 132

31 Appendix 133

31.1 Global Markets Direct Research Methodology 133

31.2 Coverage 134

31.3 Secondary Research 134

31.4 Primary Research 135

31.5 Models 135

31.6 Forecasts 136

31.7 Expert Panel Validation 136

31.8 Currency Conversion 137

31.9 Contact Us 138

31.10 Disclaimer 1381.1 List of Tables 3

Table 1: United States Healthcare Expenditure, 2003-2010 21

Table 2: United States Healthcare Expenditure by Age (per person), 2000-2003 22

Table 3: United States Healthcare Expenditure by Sex (per person), 2000-2003 22

Table 4: United States Healthcare Expenditure by Race (per person), 2000-2003 22

Table 5: United States Personal Healthcare Expenditure by Type, 2000-2004 23

Table 6: United States Personal Healthcare Expenditure by Source, 2000-2004 24

Table 7: Total Number of Doctors in the United States, 2003-2010 27

Table 8: Number of Doctors by Specialty in the United States, 2003-2010 28

Table 9: Doctors by Region (Number per 10,000 Civilian Population), 2002-2004 29

Table 10: Doctors by Region (Number per 10,000 Civilian Population), 2002-2004 (Cont.) 30

Table 11: Total Hospitals in the United States, 2000-2004 31

Table 12: Community Hospitals by Number of Beds in the United States, 2000-2004 31

Table 13: Number of Hospital Beds in the United States, 2000-2004 31

Table 14: Number of Hospital Beds by Range in the United States, 2000-2004 32

Table 15: United States Healthcare Trade Statistics, 2001-2006 33

Table 16: Medical Equipment Registration Fee in United States, 2007 40

Table 17: Medical Device Approval Time in United States, 2004 40

Table 18: Patient Monitoring Cross Country Comparison, Revenue ($ mn), 2000-2015 45

Table 19: Patient Monitoring, United States, Overall Revenue ($ mn), 2000-2015 46

Table 20: Patient Monitoring, United States, Portfolio Analysis, 2000-2015 47

Table 21: Patient Monitoring, United States, Overall Revenue ($ mn), Historic, 2000-2008 48

Table 22: Patient Monitoring, United States, Overall Revenue ($ mn), Forecast, 2008-2015 49

Table 23: Patient Monitoring, United States, Overall Volume (Units), 2000-2015 50

Table 24: Patient Monitoring, United States, Overall Volume (Units), Historic, 2000-2008 50

Table 25: Patient Monitoring, United States, Overall Volume (Units), Forecast, 2008-2015 51

Table 26: Patient Monitoring, United States, Company Share by Revenue ($ mn), 2006-2007 52

Table 27: Micro-Electromechanical Systems, United States, Revenue ($ mn), Historic, 2000-2008 53

Table 28: Micro-Electromechanical Systems, United States, Revenue ($ mn), Forecast, 2008-2015 54

Table 29: Micro-Electromechanical Systems, United States, Volume (Units), Historic, 2000-2008 55

Table 30: Micro-Electromechanical Systems, United States, Volume (Units), Forecast, 2008-2015 56

Table 31: Micro-Electromechanical Systems, United States, Average Price ($), Historic, 2000-2008 57

Table 32: Micro-Electromechanical Systems, United States, Average Price ($), Forecast, 2008-2015 57

Table 33: Micro-Electromechanical Systems, United States, Distribution Share by Revenue ($mn), 2007-2008 58

Table 34: Micro-Electromechanical Systems, United States, Company Share by Revenue ($ mn), 2006-2007 59

Table 35: Multiparameter Patient Monitoring, United States, Overall Revenue ($ mn) by Segment, Historic, 2000-2008 60

Table 36: Multiparameter Patient Monitoring, United States, Overall Revenue ($ mn) by Segment, Forecast, 2008-2015 61

Table 37: Multiparameter Patient Monitoring, United States, Overall Volume (Units) by Segment, Historic, 2000-2008 62

Table 38: Multiparameter Patient Monitoring, United States, Overall Volume (Units) by Segment, Forecast, 2008-2015 63

Table 39: Multiparameter Patient Monitoring, United States, Average Price ($), Historic, 2000-2008 64

Table 40: Multiparameter Patient Monitoring, United States, Average Price ($), Forecast, 2008-2015 64

Table 41: Multiparameter Patient Monitoring, United States, Distribution Share by Revenue ($mn), 2007-2008 65

Table 42: Multiparameter Patient Monitoring, United States, Company Share by Revenue ($ mn), 2006-2007 66

Table 43: Non-Invasive Blood Pressure Monitors, United States, Overall Revenue ($ mn) by Segment, Historic, 2000-2008 67

Table 44: Non-Invasive Blood Pressure Monitors, United States, Overall Revenue ($ mn) by Segment, Forecast, 2008-2015 68

Table 45: Non-Invasive Blood Pressure Monitors, United States, Overall Volume (Units) by Segment, Historic, 2000-2008 69

Table 46: Non-Invasive Blood Pressure Monitors, United States, Overall Volume (Units) by Segment, Forecast, 2008-2015 70

Table 47: Non-Invasive Blood Pressure Monitors, United States, Average Price ($), Historic, 2000-2008 71

Table 48: Non-Invasive Blood Pressure Monitors, United States, Average Price ($), Forecast, 2008-2015 71

Table 49: Non-Invasive Blood Pressure Monitors, United States, Distribution Share by Revenue ($mn), 2007-2008 72

Table 50: Non-Invasive Blood Pressure Monitors, United States, Company Share by Revenue ($ mn), 2006-2007 73

Table 51: Remote Patient Monitoring, United States, Revenue ($ mn), Historic, 2000-2008 74

Table 52: Remote Patient Monitoring, United States, Revenue ($ mn), Forecast, 2008-2015 75

Table 53: Remote Patient Monitoring, United States, Volume (Units), Historic, 2000-2008 76

Table 54: Remote Patient Monitoring, United States, Volume (Units), Forecast, 2008-2015 77

Table 55: Remote Patient Monitoring, United States, Average Price ($), Historic, 2000-2008 78

Table 56: Remote Patient Monitoring, United States, Average Price ($), Forecast, 2008-2015 78

Table 57: Remote Patient Monitoring, United States, Distribution Share by Revenue ($mn), 2007-2008 78

Table 58: Remote Patient Monitoring, United States, Company Share by Revenue ($ mn), 2006-2007 79

Table 59: Wireless and Ambulatory Monitoring, United States, Overall Revenue ($ mn) by Segment, Historic, 2000-2008 80

Table 60: Wireless and Ambulatory Monitoring, United States, Overall Revenue ($ mn) by Segment, Forecast, 2008-2015 81

Table 61: Wireless and Ambulatory Monitoring, United States, Overall Volume (Units) by Segment, Historic, 2000-2008 82

Table 62: Wireless and Ambulatory Monitoring, United States, Overall Volume (Units) by Segment, Forecast, 2008-2015 83

Table 63: Wireless and Ambulatory Monitoring, United States, Average Price ($), Historic, 2000-2008 84

Table 64: Wireless and Ambulatory Monitoring, United States, Average Price ($), Forecast, 2008-2015 84

Table 65: Wireless and Ambulatory Monitoring, United States, Distribution Share by Revenue ($mn), 2007-2008 85

Table 66: Wireless and Ambulatory Monitoring, United States, Company Share by Revenue ($ mn), 2006-2007 86

Table 67: GE Healthcare Pipeline Products by Equipment Type 87

Table 68: GE Healthcare Pipeline Products By Development Stage 87

Table 69: GE Healthcare Pipeline Products By Therapy Area 88

Table 70: GE Healthcare Pipeline Products By Clinical Trials 88

Table 71: Philips Medical Systems Pipeline Products by Equipment Type 93

Table 72: Philips Medical Systems Pipeline Products By Development Stage 93

Table 73: Philips Medical Systems Pipeline Products By Therapy Area 93

Table 74: Philips Medical Systems Pipeline Products By Clinical Trials 94

Table 75: Philips Medical Systems Pipeline Products By News Summaries 94

Table 76: OMRON HEALTHCARE Co., Ltd. Pipeline Products by Equipment Type 96

Table 77: OMRON HEALTHCARE Co., Ltd. Pipeline Products By Development Stage 96

Table 78: OMRON HEALTHCARE Co., Ltd. Pipeline Products By Therapy Area 96

Table 79: OMRON HEALTHCARE Co., Ltd. Pipeline Products By News Summaries 96

Table 80: Abbott Laboratories Pipeline Products by Equipment Type 103

Table 81: Abbott Laboratories Pipeline Products By Development Stage 103

Table 82: Abbott Laboratories Pipeline Products By Therapy Area 103

Table 83: Abbott Laboratories Pipeline Products By Clinical Trials 103

Table 84: Abbott Laboratories Pipeline Products By News Summaries 104

Table 85: Analogic Corporation Pipeline Products by Equipment Type 108

Table 86: Analogic Corporation Pipeline Products By Development Stage 108

Table 87: Analogic Corporation Pipeline Products By Therapy Area 108

Table 88: Critical Signal Technologies Pipeline Products by Equipment Type 110

Table 89: Critical Signal Technologies Pipeline Products by Development Stage 110

Table 90: Critical Signal Technologies Pipeline Products By Therapy Area 110

Table 91: EarlySense Pipeline Products by Equipment Type 112

Table 92: EarlySense Pipeline Products by Development Stage 112

Table 93: EarlySense Pipeline Products By Therapy Area 112

Table 94: EarlySense Pipeline Products By Clinical Trials 113

Table 95: EarlySense Pipeline Products By News Summaries 113

Table 96: Hypertension Diagnostics, Inc. Pipeline Products by Equipment Type 114

Table 97: Hypertension Diagnostics, Inc. Pipeline Products by Development Stage 114

Table 98: Hypertension Diagnostics, Inc. Pipeline Products By Therapy Area 114

Table 99: Woolsthorpe, LLC Pipeline Products by Equipment Type 116

Table 100: Woolsthorpe, LLC Pipeline Products by Development Stage 116

Table 101: Woolsthorpe, LLC Pipeline Products By Therapy Area 116

Table 102: Woolsthorpe, LLC Pipeline Products By Clinical Trials 117

Table 103: Woolsthorpe, LLC Pipeline Products By News Summaries 117

Table 104: Adidas International Acquires Textronics From Physic Ventures 120

Table 105: GE Healthcare To Acquire Minority Interest In Living Independently Group 121

Table 106: Welch Allyn And ZOLL Medical Form Partnership 122

Table 107: GE Healthcare Enters Into An Agreement With Living Independently Group 123

Table 108: SunTech Medical Enters Into An Agreement With GE Healthcare 124

Table 109: USD to Local Currency, Average Exchange Rate 2008 1371.2 List of Figures 3

Figure 1: United States, Healthcare Expenditure by Source, 2003 21

Figure 2: United States, Healthcare Infrastructure, Top Level View, 2007 26

Figure 3: Healthcare Expenses Segmentation by End User 27

Figure 4: Medical Equipment Approval Process in the United States, 2007 35

Figure 5: PMA Approval Process in the United States, 2007 37

Figure 6: The 510(k) Approval Process for Medical Devices in the United States, 2007 38

Figure 7: Reimbursement Structure in the United States, 2007 43

Figure 8: Distribution Structure of Medical Equipment in the United States, 2006 44

Figure 9: Patient Monitoring Cross Country Comparison, Revenue ($ mn), 2000-2015 45

Figure 10: Patient Monitoring, United States, Overall Revenue ($ mn), 2000-2015 46

Figure 11: Patient Monitoring, United States, Portfolio Analysis, 2000-2015 47

Figure 12: Patient Monitoring, United States, Overall Revenue ($ mn), Historic, 2000-2008 48

Figure 13: Patient Monitoring, United States, Overall Revenue ($ mn), Forecast, 2008-2015 49

Figure 14: Patient Monitoring, United States, Company Share (%), 2007 52

Figure 15: Micro-Electromechanical Systems, United States, Revenue ($ mn), Historic, 2000-2008 53

Figure 16: Micro-Electromechanical Systems, United States, Revenue ($ mn), Forecast, 2008-2015 54

Figure 17: Micro-Electromechanical Systems, United States, Volume (Units), Historic, 2000-2008 55

Figure 18: Micro-Electromechanical Systems, United States, Volume (Units), Forecast, 2008-2015 56

Figure 19: Micro-Electromechanical Systems, United States, Company Share (%), 2007 59

Figure 20: Multiparameter Patient Monitoring, United States, Overall Revenue ($ mn) by Segment, Historic, 2000-2008 60

Figure 21: Multiparameter Patient Monitoring, United States, Overall Revenue ($ mn) by Segment, Forecast, 2008-2015 61

Figure 22: Multiparameter Patient Monitoring, United States, Overall Volume (Units) by Segment, Historic, 2000-2008 62

Figure 23: Multiparameter Patient Monitoring, United States, Overall Volume (Units) by Segment, Forecast, 2008-2015 63

Figure 24: Multiparameter Patient Monitoring, United States, Company Share (%), 2007 66

Figure 25: Non-Invasive Blood Pressure Monitors, United States, Overall Revenue ($ mn) by Segment, Historic, 2000-2008 67

Figure 26: Non-Invasive Blood Pressure Monitors, United States, Overall Revenue ($ mn) by Segment, Forecast, 2008-2015 68

Figure 27: Non-Invasive Blood Pressure Monitors, United States, Overall Volume (Units) by Segment, Historic, 2000-2008 69

Figure 28: Non-Invasive Blood Pressure Monitors, United States, Overall Volume (Units) by Segment, Forecast, 2008-2015 70

Figure 29: Non-Invasive Blood Pressure Monitors, United States, Company Share (%), 2007 73

Figure 30: Remote Patient Monitoring, United States, Revenue ($ mn), Historic, 2000-2008 74

Figure 31: Remote Patient Monitoring, United States, Revenue ($ mn), Forecast, 2008-2015 75

Figure 32: Remote Patient Monitoring, United States, Volume (Units), Historic, 2000-2008 76

Figure 33: Remote Patient Monitoring, United States, Volume (Units), Forecast, 2008-2015 77

Figure 34: Remote Patient Monitoring, United States, Company Share (%), 2007 79

Figure 35: Wireless and Ambulatory Monitoring, United States, Overall Revenue ($ mn) by Segment, Historic, 2000-2008 80

Figure 36: Wireless and Ambulatory Monitoring, United States, Overall Revenue ($ mn) by Segment, Forecast, 2008-2015 81

Figure 37: Wireless and Ambulatory Monitoring, United States, Overall Volume (Units) by Segment, Historic, 2000-2008 82

Figure 38: Wireless and Ambulatory Monitoring, United States, Overall Volume (Units) by Segment, Forecast, 2008-2015 83

Figure 39: Wireless and Ambulatory Monitoring, United States, Company Share (%), 2007 86

Figure 40: Philips Medical Systems Value Chain Analysis 90

Figure 41: OSI Systems, Inc. Value Chain Analysis 97

Figure 42: Abbott Laboratories Value Chain Analysis 100

Figure 43: Analogic Corporation Value Chain Analysis 106

Figure 44: Global Markets Direct Methodology 133

To order this report:

United States Patient Monitoring Investment Opportunities, Analysis and Forecasts to 2015

http://www.reportlinker.com/p0109554/United-States-Patient-Monitoring-Investment-Opportunities-Analysis-and-Forecasts-to-2015.html

More market research reports here!